Copyright
©The Author(s) 2022.
World J Clin Cases. Jan 7, 2022; 10(1): 166-176
Published online Jan 7, 2022. doi: 10.12998/wjcc.v10.i1.166
Published online Jan 7, 2022. doi: 10.12998/wjcc.v10.i1.166
Figure 2 Representative images of localized chronic eczema lesions before and 2 wk after treatment.
Skin lesion of a patient in the intralesional 5-FU+TA treatment group (A) at baseline and (B) 2 wk after 5-FU+TA treatment. Skin lesion of a patient in the intralesional TA treatment group (C) at baseline and (D) 2 wk after TA treatment. 5-FU: 5-fluorouracil; TA: triamcinolone.
- Citation: Wu Y, Wang GJ, He HQ, Qin HH, Shen WT, Yu Y, Zhang X, Zhou ML, Fei JB. Low-dose intralesional injection of 5-fluorouracil and triamcinolone reduces tissue resident memory T cells in chronic eczema. World J Clin Cases 2022; 10(1): 166-176
- URL: https://www.wjgnet.com/2307-8960/full/v10/i1/166.htm
- DOI: https://dx.doi.org/10.12998/wjcc.v10.i1.166